17, 2024 -- The FDA last week approved Nemluvio for treating moderate to severe atopic dermatitis ... before starting treatment. Also, patients must notify their doctor about all medications ...
2024 EADV 2024 Children With Severe AD Catch Up on Growth With Dupilumab Effective treatment with dupilumab may allow younger children with severe atopic dermatitis and short stature to catch up ...
The CHMP has recommended nemolizumab’s approval for subcutaneous use for the treatment of moderate-to-severe atopic dermatitis in patients aged 12 years and older who are candidates for systemic ...